The chemical inhibitors used in this treatment target the enzyme polymerase (PARP1), which is normally involved in the repair of DNA single-strand breaks – a common form of spontaneous DNA lesions. Chemical inhibition of the PARP1 protein results in reduced occurrence of these single-strand break repairs.